PR Newswire
NEW YORK, Oct. 7, 2016
NEW YORK, Oct. 7, 2016 /PRNewswire/ -- Levi & Korsinsky,
LLP announces that it has commenced an investigation of ProNAi Therapeutics Inc. ("ProNAi" or the "Company") (NASDAQ: DNAI)
concerning possible violations of federal securities laws by the Company and/or certain of its officers and directors. To obtain
additional information about the investigation, go to:
http://zlk.9nl.com/pronai-dnai
or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington
D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud,
representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not
guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
Logo - http://photos.prnewswire.com/prnh/20120409/MM84375LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/investor-alert-levi--korsinsky-llp-announces-an-investigation-involving-possible-securities-fraud-violations-by-pronai-therapeutics-inc-and-certain-officers-and-directors----dnai-300341449.html
SOURCE Levi & Korsinsky, LLP
